Key facts
- It has raised $4.2M; the latest was Later Stage VC ($4.2M) in Nov 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Yuanhe Vision
- ·The full record, as it builds
Funding rounds
No funding rounds for Yuanhe Vision are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Yuanhe Vision
Provider of vision rehabilitation technologies intended for optometric training, clinical services, and franchise operations. The company includes patented technologies for correcting myopia, astigmatism, amblyopia, strabismus, and hyperopia, along with vision testing, rehabilitation training, product development, and chain operation models, enabling healthcare providers and families to access scientifically designed eye care solutions, improve visual function, and expand professional optometry services through a nationwide network of over 400 franchise stores and specialized clinics.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2016
- Website
- kmsg.net.cn/
- Ownership
- Privately Held (backing)
Yuanhe Vision doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Yuanhe Vision shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Yuanhe Vision in its N-PORT filings yet. We sweep new filings monthly.